RYZODEG Drug & Market Forecast Report 2023-2032: Reveals Comprehensive Insights for Type 1 Diabetes Mellitus Treatment - Mechanism of Action, Clinical Assessments, Market Dynamics, Emerging Competitors
30 janv. 2024 06h58 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "RYZODEG Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Offering an in-depth analysis of the...
Cell Therapies for Type 1 Diabetes: 2023-2030 Industry Outlook Featuring Analysis of Leading Players Novo Nordisk, Sanofi, Vertex Pharmaceuticals, Sernova, and Throne Biotechnologies
30 janv. 2024 04h49 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapies for Type 1 Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment" report has been...
Global Insulin Delivery Pen Market Forecast Shows Strong Growth up to 2032 with Technological Advancements and Rising Diabetes Prevalence
30 janv. 2024 03h40 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Delivery Pen Market Size, Growth, Trends, Share and Forecast 2024 - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Insulin Delivery Devices Market: Surge in Global Diabetes Prevalence Catalyzing Robust Growth to 2031
29 janv. 2024 12h35 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Biosimilar Insulin Market Global Industry Analysis - Market Set to Surge, Spearheaded by High Demand in APAC and Cost-Effective Innovations
29 janv. 2024 12h24 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
PRV-031 (teplizumab) Drug Insight and Market Forecast to 2032: Highlights Opportunities Across Key Regions
29 janv. 2024 12h21 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "PRV-031 Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report reveals extensive insights...
Insulin Delivery Pipeline Clinical Research Report 2023: Analysis of Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
24 janv. 2024 15h16 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update"...
Insulin Pumps Market Research Reveals Enhanced Growth and Advanced Pipeline Stages
24 janv. 2024 15h15 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pumps Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report...
Diabetes Care Advances: LEVEMIR Drug Insight and 2032 Market Forecast Revealed
24 janv. 2024 10h50 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LEVEMIR Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The healthcare industry has taken a...
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
09 janv. 2024 06h00 HE
|
Embecta Corp.
embecta has submitted a 510(k) premarket filing to the FDA for a proprietary disposable insulin delivery system.